- Accelerator
- Angel Investor
- Applicant Assistance Program (AAP)
- Biotech Hub
- Burn Rate
- Commercialization Accelerator Program (CAP)
- CDC
- CEO
- CFO
- Cofounder
- Contract Research Organization
- COO
- Corporation
- Crowdfunding
- CSO
- Customer Discovery
- Dilutive
- Non-Dilutive
- EIN
- eRA
- Equity
- Exit Strategy
- FAST
- FDA
- FTO
- Fulfillment Strategy
- Funding Opportunity Announcement
- Funding Rounds
- I-Corps
- Impact Score
- In Vitro
- In Vivo
- Incubator
- Inflection Point
- IPO
- Intellectual Property
- LLC
- Material Transfer Agreement (MTA)
- Minimum Viable Product
- NIH
- Non-Disclosure Agreement (NDA)
- NSF
- Omnibus Solicitation
- Patent
- Peptibody
- Phase I
- Phase II
- Phase III
- Pitch
- Prior Art
- Program Official
- Proof of Concept
- Prospecting
- Return on Investment
- SBA
- SBIR
- Seed Funding
- Series A Funding
- Shares
- Specific Aims
- Startup
- Strategic Investor
- Strategic Partners
- STTR
- Summary Statement
- TABA
- Tangible Assets
- Technology Readiness Level (TRL)
- Technology Transfer Office
- Trademark
- Valley of Death
- Value Proposition
- Venture Capital
This project is funded by National Institute of General Medical Sciences (Grants 1R43 GM131458-01 & 2R GM131458-02)
Footer
clinicaltoolsinc@gmail.com
101 A Market St
Chapel Hill, NC 27516
919-960-8118